Adage Capital Partners’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.6M | Buy |
397,400
+3,400
| +0.9% | +$125K | 0.02% | 522 |
|
|
2025
Q1 | $13.9M | Sell |
394,000
-256,000
| -39% | -$9.05M | 0.03% | 503 |
|
|
2024
Q4 | $28.4M | Buy |
650,000
+360,000
| +124% | +$15.7M | 0.05% | 346 |
|
|
2024
Q3 | $13.2M | Buy |
290,000
+120,000
| +71% | +$5.44M | 0.02% | 557 |
|
|
2024
Q2 | $6.6M | Sell |
170,000
-30,000
| -15% | -$1.16M | 0.01% | 677 |
|
|
2024
Q1 | $6.45M | Buy |
+200,000
| New | +$6.45M | 0.01% | 666 |
|
|
2023
Q4 | – | Sell |
-30,000
| Closed | -$830K | – | 920 |
|
|
2023
Q3 | $830K | Buy |
+30,000
| New | +$830K | ﹤0.01% | 770 |
|
|
2020
Q2 | – | Sell |
-25,000
| Closed | -$548K | – | 793 |
|
|
2020
Q1 | $548K | Buy |
+25,000
| New | +$548K | ﹤0.01% | 698 |
|